Why Arafura, Mayne Pharma, Pilbara Minerals, and Tyro shares are dropping today

These ASX shares are dropping on Monday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to start the week in a positive fashion. In afternoon trade, the benchmark index is up 0.5% to 7,340.4 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are dropping:

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.

Image source: Getty Images

Arafura Rare Earths Ltd (ASX: ARU)

The Arafura share price is down 5.5% to 41.5 cents. This has been driven by the company's institutional placement. The rare earths developer has received firm commitments for a $121 million placement to accelerate the Nolans Project development schedule. These funds are being raised at a 15.9% discount of 37 cents per new share.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is down over 10% to 21.5 cents. This morning the pharmaceutical company announced that it has signed a transaction agreement and related license agreement for a portfolio of on-market women's health products from TherapeuticsMD for US$140 million. The products' net revenue in the third quarter of 2022 were US$20.9 million and gross profit was US$17.1 million.

Pilbara Minerals Ltd (ASX: PLS)

The Pilbara Minerals share price is down 4.5% to $4.64. This is despite the lithium giant being added to the ASX 50 index at the quarterly rebalance. Investors appear to have concerns about lithium prices following a couple of bearish broker notes and news of a new major lithium mine development.

Tyro Payments Ltd (ASX: TYR)

The Tyro share price is down 5.5% to $1.62. Investors have been selling this payments company's shares following the release of a transaction update. According to the release, transaction value growth slowed to 16% during the month of November. This is a sharp slowdown compared to its year to date growth rate of 43%.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Tyro Payments. The Motley Fool Australia has recommended Tyro Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »